AAAAAA

   
Results: 1-10 |
Results: 10
A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps
Authors: Catargi, B Breilh, D Gin, H Rigalleau, V Saux, MC Roger, P Tabarin, A
Citation: B. Catargi et al., A randomized study comparing blood glucose control and risk of severe hypoglycemia achieved by non-programmable versus programmable external insulin pumps, DIABETE MET, 27(3), 2001, pp. 323-327
Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas
Authors: Valli, N Catargi, B Ronci, N Vergnot, V Leccia, F Ferriere, JM Chene, G Grenier, N Laurent, F Tabarin, A
Citation: N. Valli et al., Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas, EUR J ENDOC, 144(4), 2001, pp. 401-408
Clinical evaluation of a newly designed compliant side port catheter for an insulin implantable pump - The EVADIAC experience
Authors: Gin, H Melki, V Guerci, B Catargi, B
Citation: H. Gin et al., Clinical evaluation of a newly designed compliant side port catheter for an insulin implantable pump - The EVADIAC experience, DIABET CARE, 24(1), 2001, pp. 175-175
Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump
Authors: Catargi, B Breilh, D Roger, P Tabarin, A
Citation: B. Catargi et al., Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump, DIABETE MET, 26(3), 2000, pp. 210-214
Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodinescintigraphy
Authors: Valli, N Catargi, B Ronci, N Leccia, F Guyot, M Roger, P Ducassou, D Tabarin, A
Citation: N. Valli et al., Evaluation of indium-111 pentetreotide somatostatin receptor scintigraphy to detect recurrent thyroid carcinoma in patients with negative radioiodinescintigraphy, THYROID, 9(6), 1999, pp. 583-589
Homocysteine, hypothyroidism, and effect of thyroid hormone replacement
Authors: Catargi, B Parrot-Roulaud, F Cochet, C Ducassou, D Roger, P Tabarin, A
Citation: B. Catargi et al., Homocysteine, hypothyroidism, and effect of thyroid hormone replacement, THYROID, 9(12), 1999, pp. 1163-1166
Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and of other possible factors affecting outcome
Authors: Catargi, B Leprat, F Guyot, M Valli, N Ducassou, D Tabarin, A
Citation: B. Catargi et al., Optimized radioiodine therapy of Graves' disease: analysis of the delivered dose and of other possible factors affecting outcome, EUR J ENDOC, 141(2), 1999, pp. 117-121
Localization of parathyroid tumors using endoscopic ultrasonography in primary hyperparathyroidism
Authors: Catargi, B Raymond, JM Lafarge-Gense, V Leccia, F Roger, P Tabarin, A
Citation: B. Catargi et al., Localization of parathyroid tumors using endoscopic ultrasonography in primary hyperparathyroidism, J ENDOC INV, 22(9), 1999, pp. 688-692
Comment on gonadotroph adenoma causing ovarian hyperstimulation
Authors: Catargi, B Felicie-Dellan, E Tabarin, A
Citation: B. Catargi et al., Comment on gonadotroph adenoma causing ovarian hyperstimulation, J CLIN END, 84(9), 1999, pp. 3404-3404
Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome
Authors: Tabarin, A Valli, N Chanson, P Bachelot, Y Rohmer, V Bex-Bachellerie, V Catargi, B Roger, P Laurent, F
Citation: A. Tabarin et al., Usefulness of somatostatin receptor scintigraphy in patients with occult ectopic adrenocorticotropin syndrome, J CLIN END, 84(4), 1999, pp. 1193-1202
Risultati: 1-10 |